Artesunate - Moligand™, ≥98% , CAS No.88495-63-0

CAS: 88495-63-0 Cat. No.: A107818 Peso molecular: 384.42 Número EC: 618-170-5
Disponible para pedir
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
4-oxo-4-{[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0?,(1)(3).0?,(1)(3)]hexadecan-10-yl]oxy}butanoic acid | ARTESUNATE [WHO-DD] | NCGC00164600-15 | Q707939 | ARTESUNATE [WHO-IP] | HY-N0193 | UNII-60W3249T9M | 4-oxo
Storage
Store at 2-8°C
Shipped In
Wet ice
 ·  off list, applied to all prices below.
Size
Estado
Price
Qty
5g
A107818-5g
2
22,90US$
25g
A107818-25g
3
82,90US$
100g
A107818-100g
2
261,90US$
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Moligand™, ≥98% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at 2-8°C Ships Wet ice Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 44 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Descripción general

Artesunate is a derivative of artemisinin and belongs to a class with antimicrobial properties. The compound is an active ingredient in the Chinese herb Artemisia annua and has been used in Malaria studies. Artesunate has been tested against 55 cell lines and demonstrated anti-cancer activity. Research shows that conditional expression of CDC25A heightens the sensitivity of tumor cells to artesunate.

Specifications

Sinónimos
4-oxo-4-{[(1R, 4S, 5R, 8S, 9R, 10S, 12R, 13R)-1, 5, 9-trimethyl-11, 14, 15, 16-tetraoxatetracyclo[10.3.1.0?, (1)(3).0?, (1)(3)]hexadecan-10-yl]oxy}butanoic acid | ARTESUNATE [WHO-DD] | NCGC00164600-15 | Q707939 | ARTESUNATE [WHO-IP] | HY-N0193 | UNII-60W3249T9M | 4-oxo
Especificaciones y pureza
Moligand™, ≥98%
Mecanismos bioquímicos y fisiológicos
Semi-synthetic artemisinin (Asc - 1308 ) derivative. Induces apoptosis of vascular endothelial cells. Shows antiangiogenenic and antiparasitaemic effects in vivo .
Condiciones de almacenamiento de almacenamiento
Store at 2-8°C
Enviado en
Wet ice
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Grado
Moligand™
Tipo de acción
INHIBITOR
Nota
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Pureza
≥98%
Propiedades del producto
ALogP2.5
Nombres e identificadores
Sonrisas canónicasCC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C
IUPAC Name4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxy]butanoic acid
InChIKeyFIHJKUPKCHIPAT-AHIGJZGOSA-N
INCHI1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16-,17-,18-,19-/m1/s1
Isómeros SMILES C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)O)C
Peso molecular 384.42
Reaxy-Rn 7496318
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=7496318&ln=

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClasePrenol lipids
SubclassSesquiterpenoids
Intermediate Tree Nodes Not available
Direct ParentArtemisinins
Alternative Parents Oxepanes  Heterocyclic fatty acids  Fatty acid esters  Trioxanes  Oxanes  Dicarboxylic acids and derivatives  Dialkyl peroxides  Carboxylic acid esters  Oxacyclic compounds  Carboxylic acids  Acetals  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAliphatic heteropolycyclic compounds
Substituents Artemisinin skeleton - Fatty acid ester - Heterocyclic fatty acid - Oxepane - Dicarboxylic acid or derivatives - Oxane - Fatty acyl - 1,2,4-trioxane - Carboxylic acid ester - Dialkyl peroxide - Oxacycle - Carboxylic acid - Acetal - Carboxylic acid derivative - Organoheterocyclic compound - Organooxygen compound - Hydrocarbon derivative - Organic oxide - Carbonyl group - Organic oxygen compound - Aliphatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as artemisinins. These are sesquiterpenoids originally isolated from the herb Artemisia annua. Their structure is based on artemisinin, a tetracyclic compound that contains a 1,2-dioxepane fused to an octahydrobenzopyran moiety. The internal peroxide bridge is believed to be a key to the mode of action of artemisinins.
External Descriptors dicarboxylic acid monoester - semisynthetic derivative - sesquiterpenoid - artemisinin derivative - cyclic acetal
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Objetivos asociados (no humanos)
Histidine-rich protein (528 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr3 Fibroblast growth factor receptor 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Schistosoma japonicum (780 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fasciola hepatica (191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania donovani (89745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium yoelii (6656 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Schistosoma mansoni (6170 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human betaherpesvirus 5 (5122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatitis B virus (7925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium yoelii nigeriensis (1119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L6 (7924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
H22 (575 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hemozoin (239 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chuk Inhibitor of nuclear factor kappa-B kinase subunit alpha (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ikbkb Inhibitor of nuclear factor kappa-B kinase subunit beta (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium malariae (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium vinckei petteri (380 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium vivax (152 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Echinococcus multilocularis (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB2B Tubulin (2175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

10 results found

Lot NumberCertificate TypeFechaArticulo
B2219341Certificate of AnalysisDec 10, 2025 A107818
L2523206Certificate of AnalysisDec 06, 2025 A107818
L2523207Certificate of AnalysisDec 06, 2025 A107818
L2523208Certificate of AnalysisDec 06, 2025 A107818
E2305312Certificate of AnalysisJan 11, 2023 A107818
E2305613Certificate of AnalysisJan 11, 2023 A107818
G2328047Certificate of AnalysisJan 11, 2023 A107818
B2219326Certificate of AnalysisDec 30, 2021 A107818
B2219525Certificate of AnalysisDec 30, 2021 A107818
H2527115Certificate of AnalysisDec 30, 2021 A107818
Propiedades químicas y físicas
SolubilidadSoluble in DMSO (25 mg/mL), and ethanol (25 mg/mL).solubility acetone: 33.4 mg/mL.
Sensibilidadheat sensitive
Rotación específica [α]5.5° (C=1,CH2Cl2)
Punto de fusión (°C)133°C
Peso molecular384.400 g/mol
XLogP32.500
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count5
Exact Mass384.178 Da
Monoisotopic Mass384.178 Da
Topological Polar Surface Area101.000 Ų
Heavy Atom Count27
Formal Charge0
Complexity623.000
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Preguntas frecuentes y artículos
Citations of This Product
Referencias
1. Jingjing Zhen, Faguang Ma, Rongxin Lin, Ming Yan, Yilin Wu.  (2023)  Porous MOFs-based self-assembled membrane with specific rebinding nanocages for selective recognition and separation at molecular level.  DESALINATION,      [PMID:] [10.1016/j.desal.2023.117124]
2. Weibai Bian, Ruixuan Zhang, Xiaohui Chen, Chuanxun Zhang, Minjia Meng.  (2023)  Three-Dimensional Porous PVDF Foam Imprinted Membranes with High Flux and Selectivity toward Artemisinin/Artemether.  MOLECULES,  28  (21): (7452).  [PMID:37959871] [10.3390/molecules28217452]
3. Kaicheng Zhang, Rongxin Lin, Ming Yan, Yilin Wu.  (2023)  Click-chemistry synergic MXene-functionalized flexible skeleton membranes for accurate recognition and separation.  JOURNAL OF COLLOID AND INTERFACE SCIENCE,      [PMID:37690308] [10.1016/j.jcis.2023.09.028]
4. Li Yuan-Ce, Zhang Qi, Zhang Hong-Yang, Wang Yan-Wen, Sun Yu-Mei, Yang Bi-Juan, Yin Jun-Lin.  (2023)  Artesunate, as an Hsp90 inhibitor, inhibits the proliferation of Burkitt’s lymphoma cells by inhibiting AKT and ERK.  Frontiers in Pharmacology,      [PMID:37719860] [10.3389/fphar.2023.1218467]
5. Jing Yan, Faguang Ma, Yilin Wu.  (2023)  Permselective and transparent wooden membrane with artemisinin-imprinted nanocages based on a MOFs@C3N4 self-assembly design.  Materials Today Nano,      [PMID:] [10.1016/j.mtnano.2023.100369]
6. Xin Zhang, Zhifang Liang, Ying Zhou, Fang Wang, Shan Wei, Bing Tan, Yujie Guo.  (2023)  Artesunate Inhibits Apoptosis and Promotes Survival in Schwann Cells via the PI3K/AKT/mTOR Axis in Diabetic Peripheral Neuropathy.  BIOLOGICAL & PHARMACEUTICAL BULLETIN,  46  (6): (764-772).  [PMID:37258141] [10.1248/bpb.b22-00619]
7. Minjia Meng, Yi Li, Hui Peng, Binrong Li, Chuanxun Zhang, Jiajia Ren, Qingluola Ren, Yan Liu, Jianming Pan.  (2023)  Hydrophilic imprinted MnO2 nanowires “coating” membrane with ultrahigh adsorption capacity for highly selective separation of Artemisinin/Artemether.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2023.143020]
8. Jie Lv, Xiaoyu Wang, Xue Zhang, Runpei Xu, Shuyang Hu, Shuangling Wang, Meng Li.  (2023)  Tumor microenvironment-responsive artesunate loaded Z-scheme heterostructures for synergistic photo-chemodynamic therapy of hypoxic tumor.  Asian Journal of Pharmaceutical Sciences,      [PMID:37252037] [10.1016/j.ajps.2023.100798]
9. Jing Yan, Kaicheng Zhang, Faguang Ma, Hang Cui, Yilin Wu.  (2023)  Scalable basswood-based PDA/GO-embedded self-assembly membrane within multilayered artemisinin-imprinted nanocage for high-selectivity cascading adsorption and transport.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2023.142277]
10. Zhong Wenzhao, Guo Feng, Chen Fangman, Law Man-Kay, Lu Jun, Shao Dan, Yu Hua, Chan Ging, Chen Meiwan.  (2022)  A multifunctional oxidative stress nanoamplifier with ROS amplification and GSH exhaustion for enhanced chemodynamic therapy.  Frontiers in Pharmacology,      [PMID:36438812] [10.3389/fphar.2022.1044083]
11. Peng Ji, Xianglong Wang, Jiabing Yin, Yansheng Yao, Wangqi Du.  (2022)  Amplification of ferroptosis with a liposomal nanoreactor cooperates with low-toxicity doxorubicin apoptosis for enhanced tumor chemotherapy.  Biomaterials Science,  10  (6): (1544-1553).  [PMID:35171184] [10.1039/D2BM00079B]
12. Sennan Qiao, Hansi Zhang, Fei Sun, Zhenyan Jiang.  (2021)  Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study.  MOLECULES,  26  (18): (5698).  [PMID:34577169] [10.3390/molecules26185698]
13. Miaomiao Long, Jiamin Xu, Wenjie Fang, Jing Mao, Jie Zhang, Shenhuan Liu, Lipeng Qiu.  (2021)  Enhanced delivery of artesunate by stimuli-responsive polymeric micelles for lung tumor therapy.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,      [PMID:] [10.1016/j.jddst.2021.102812]
14. Fereja Shemsu Ligani, Fang Zhongying, Li Ping, Guo Jinhan, Fereja Tadesse Haile, Chen Wei.  (2021)  “Turn-off” sensing probe based on fluorescent gold nanoclusters for the sensitive detection of hemin.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY,  413  (6): (1639-1649).  [PMID:33483839] [10.1007/s00216-020-03126-1]
15. Mengqi Bai, Li Qiang, Minjia Meng, Binrong Li, Suao Wang, Yilin Wu, Li Chen, Jiangdong Dai, Yan Liu, Jianming Pan.  (2020)  Upper surface imprinted membrane prepared by magnetic guidance phase inversion method for highly efficient and selective separation of Artemisinin.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2020.126899]
16. Huang Ming-Zhi, Zhuang Yong, Ning Xu, Zhang Hao, Shen Zhi-Min, Shang Xian-Wen.  (2020)  Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis.  BIOSCIENCE REPORTS,  40  (7):   [PMID:32542308] [10.1042/BSR20194387]
17. Yilin Wu, Wendong Xing, Minjia Meng, Jian Lu, Faguang Ma, Jia Gao, Xinyu Lin, Chao Yu.  (2020)  Multiple-functional molecularly imprinted nanocomposite membranes for high-efficiency selective separation applications: An imitated core-shell TiO2@PDA-based MIMs design.  COMPOSITES PART B-ENGINEERING,      [PMID:] [10.1016/j.compositesb.2020.108123]
18. Zhu Wang, Qianqian Wang, Tao He, Wen Li, Yan Liu, Yuan Fan, Yanping Wang, Qi Wang, Jie Chen.  (2020)  The combination of artesunate and carboplatin exerts a synergistic anti-tumour effect on non-small cell lung cancer.  CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY,  47  (6): (1083-1091).  [PMID:32072678] [10.1111/1440-1681.13287]
19. Peng Ji, Haiqin Huang, Shirui Yuan, Le Wang, Siqi Wang, Yiwei Chen, Na Feng, Hanitrarimalala Veroniaina, Ziheng Wu, Zhenghong Wu, Xiaole Qi.  (2019)  ROS-Mediated Apoptosis and Anticancer Effect Achieved by Artesunate and Auxiliary Fe(II) Released from Ferriferous Oxide-Containing Recombinant Apoferritin.  Advanced Healthcare Materials,  (23): (1900911).  [PMID:31701665] [10.1002/adhm.201900911]
20. Renjie Xu, Ting Han, Li Shen, Jianguo Zhao, Xiang’an Lu.  (2019)  Solubility Determination and Modeling for Artesunate in Binary Solvent Mixtures of Methanol, Ethanol, Isopropanol, and Propylene Glycol + Water.  JOURNAL OF CHEMICAL AND ENGINEERING DATA,      [PMID:] [10.1021/acs.jced.8b00988]
21. Yao Yuyuan, Guo Qinglong, Cao Yue, Qiu Yangmin, Tan Renxiang, Yu Zhou, Zhou Yuxin, Lu Na.  (2018)  Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.  JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,  37  (1): (1-14).  [PMID:30477536] [10.1186/s13046-018-0960-7]
22. Ting Li, Qingwen Zeng, Xingming Chen, Guojiang Wang, Haiqing Zhang, Aihua Yu, Hairui Wang, Yang Hu.  (2018)  The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway.  Molecular Medicine Reports,  17  (6): (8385-8390).  [PMID:29693177] [10.3892/mmr.2018.8887]
23. Hailong Huang, Xianghui Wang, Hao Ge, Min Xu.  (2016)  Multifunctional Magnetic Cellulose Surface-Imprinted Microspheres for Highly Selective Adsorption of Artesunate.  ACS Sustainable Chemistry & Engineering,      [PMID:] [10.1021/acssuschemeng.6b00386]
24. Hongqiao Wei, Yongxin Chen, Zhenmin Qin, Honglei Wang, Yujia Liu, Tang Song, Yong Wu, Wanxiang Hu, Xiaowei Huang, Guodong Lu, Jing Zhou.  (2025)  Artesunate demonstrates neuroprotective effect through activation of lysosomal function and inhibition of cGAS-STING pathway.  NEUROPHARMACOLOGY,      [PMID:40118208] [10.1016/j.neuropharm.2025.110426]
25. Lirong Zhang, Beibei Yu, Zijian Zhuang, Zhengzou Fang, Mengke Lu, Huijun Yu, Xiao Xu, Xin Sun, Fengyi Du, Miaomiao Zhang.  (2024)  Autocatalytic Artesunate Coordinated ZIF-8 Nanoplatforms with Metal-Polyphenol Network Coating for Targeted Tumor Chemodynamic Therapy.  ACS Applied Nano Materials,      [PMID:] [10.1021/acsanm.4c00403]
26. Wang Da, Bai Yunfei, Cheng Guogang, Shen Shengqiang, Xiao Gengwu, Ma Demei, Zhao Ganggang, Chen Wei, Li Tianshi, Zhang Litao, Ge Xiaohu.  (2024)  Exosome-drug conjugates delivery: a promising strategy for ameliorating the pharmacokinetic profile of artesunate.  Frontiers in Bioengineering and Biotechnology,      [PMID:39188369] [10.3389/fbioe.2024.1437787]
27. Xiaoyu Wang, Chunzhe Xu, Hantao Tian, Yu Pang, Jie Lv, Meng Li.  (2025)  FeS embedded bioreactor collaborate with artesunate for cascade-catalytic tumor ferroptosis.  JOURNAL OF COLLOID AND INTERFACE SCIENCE,      [PMID:40184656] [10.1016/j.jcis.2025.137479]
28. Yiqun Zhang, Ni Zhang, Jianghao Xing, Yiwei Sun, Xu Jin, Cailiang Shen, Liang Cheng, Yuanyin Wang, Xianwen Wang.  (2024)  In situ hydrogel based on Cu–Fe3O4 nanoclusters exploits oxidative stress and the ferroptosis/cuproptosis pathway for chemodynamic therapy.  BIOMATERIALS,      [PMID:38943822] [10.1016/j.biomaterials.2024.122675]
29. Meiting Li, Zhuoyin Liu, Dan Peng, Yadong Liu, Lili Cheng, Baizhu Chen, Jie Liu.  (2025)  Multifunctional porous organic polymer-based hybrid nanoparticles for sonodynamically enhanced cuproptosis and synergistic tumor therapy.  Acta Biomaterialia,      [PMID:39993518] [10.1016/j.actbio.2025.02.045]
30. Cijun Shuai, Gao Pan, Tiantian He, Xiong Shuai, Ping Wu, Qi Zhong.  (2024)  Photothermal effect of graphene oxide accelerate singlet oxygen release from artesunate to endow the scaffold with antibacterial properties.  Materials Today Communications,      [PMID:] [10.1016/j.mtcomm.2024.109058]
31. Minjia Meng, Jiajia Ren, Chuanxun Zhang, Wanqi Du, Jixiang Wang.  (2024)  Polyvinylidene Fluoride-Based Nanowire-Imprinted Membranes with High Flux for Efficient and Selective Separation of Artemisinin/Artemether.  MOLECULES,  29  (16): (3868).  [PMID:39202947] [10.3390/molecules29163868]
32. Jiahe Chen, Yingying Zhang, Xin Guo, Yiyang Qiao, Ping Yu.  (2024)  Three-dimensional porous imprinted UiO-66-D@loofah membrane for targeted separation of Artemisinin by smart situ deposition method.  SEPARATION AND PURIFICATION TECHNOLOGY,      [PMID:] [10.1016/j.seppur.2024.126523]
33. Chenyu Zhao, Rong Wang, Siyuan Luo, Ya Wang, Zhenhai Gan, Jingran Di, Daocheng Wu.  (2025)  Molecular Stacking@Infinite Coordination Polymer Nanocomposites for Tumor Continuous High-Intensity Photothermal–Thermodynamic Alternate Cycle Therapy and Chemotherapy.  ACS Nano,      [PMID:40719356] [10.1021/acsnano.5c07772]
34. Shichen Zhang, Lei Guo, Yixin Tang, Yixing Wang, Heshi Liu, Chang Liu, Xiuzhang Yan, Congcong Duan, Huanyan Dai, Bing Han, Caina Xu.  (2025)  Self-reinforced nanoreactor for apoptosis/ferroptosis synergistic therapy of head and neck squamous cell carcinoma.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2025.166941]
35. Wang Yun, Li Zhongrui, Li Renshi, Han Chao, Wang Lei.  (2024)  Berberine-based self-assembly agents with enhanced synergistic antitumor efficacy.  Frontiers in Pharmacology,      [PMID:38545553] [10.3389/fphar.2024.1333087]
36. Han-Xiao Tang, Zhi-Hang He, Chen-Guang Liu, Xiao-Ke Zheng, Zhi-Juan Zhang.  (2024)  Tumor Microenvironment-Responsive Biodegradable Nanomedicine for Self-Enhanced Synergistic Chemo-, Photothermal, and Chemodynamic Therapy.  ACS Applied Materials & Interfaces,      [PMID:39303011] [10.1021/acsami.4c09671]
37. Jingru Cui, Zhonghui Xue, Zhengxian Zhang, Huanhuan Zhu, Mingsan Miao, Yagang Song, Xiaofang Li, Huahui Zeng, Xiangxiang Wu.  (2025)  GSH-Triggered Self-Cascading Nanoreactor Integrates Efficient ICD Induction and Immune Checkpoint Blockade for Pancreatic Cancer Therapy.  ADVANCED FUNCTIONAL MATERIALS,      [PMID:] [10.1002/adfm.202520855]
38. Zhaoyang Gan, Chang Liu, Shaopeng Li, Chengda Ju, Sixuan Huo, Jing Wang, Yulong Lin.  (2025)  Artesunate loaded core-shell nanoplatform for the chemo-chemodynamic-photothermal synergistic cancer therapy.  COLLOIDS AND SURFACES B-BIOINTERFACES,      [PMID:40393095] [10.1016/j.colsurfb.2025.114810]
39. Ji Hongyan, Huang Yutao, Tian Jingxuan, Bo Ruonan, Heng Xin, Yang Junyi, Huang Yifan, Wang Xiangyu, Tan Qingfeng, Gao Hua, Chen Linwei, Chen Jing.  (2025)  Chrysosplenetin acts as a homeostasis stabilizer with dual-function in shattering Plasmodium berghei K173 resistance to artemisinin driven by both ABC transporters and heme-ROS/GSH axis.  Parasites & Vectors,  18  (1): (1-22).  [PMID:41068871] [10.1186/s13071-025-07018-0]
40. Chen Chen, Xinlu Li, Weixia Zhu, Yu Chen, Jie Tang, Shun Yao.  (2025)  The suppository containing a complex of active pharmaceutical ingredient-ionic liquid (API-IL) derived from mefloquine and artesunate with Zeolitic imidazolate framework-8.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2025.169534]
41. Yijie Wang, Xinyu Yu, Xinyu Zhang, Xiaohui He, Yongxin Tang, Ling Fang, Richard Culleton, Qingfeng Zhang, Weifu Dong, Jun Cao.  (2026)  Development and evaluation of novel zein-based artemisinin sustained-release formulation for treating drug-resistant malaria.  mBio,      [PMID:41524404] [10.1128/mbio.03696-25]
42. Xifan Zheng, Bo Yu, Yuansong Song, Yeping Chen, Zeming Li, Jun Yao.  (2026)  Artemisinin exerts anti-inflammatory effects in osteoarthritis through the inhibition of TGF-β1 signaling.  Frontiers in Immunology,      [PMID:41694337] [10.3389/fimmu.2026.1717045]
43. Haonan Wu, Xuan Zhang, Xiaomei Shu, Hongyuan Zhang, Wenhu Zhou, Shenwu Zhang, Cong Luo.  (2026)  Molecularly Tailored Artesunate Nanomedicine with Well-Balanced Nanoassembly and Anticancer Performance.  Pharmaceutics,  18  (2): (240).  [PMID:41754981] [10.3390/pharmaceutics18020240]
44. Enkang Tong, Xiaofei Dong, Yifan Ren, Lingxue Gong, Cuicui Zhao, Rongrong Nie, Xiangfeng Meng.  (2026)  Artesunate ameliorates Staphylococcus aureus-induced mandibular osteomyelitis and promotes osteogenic differentiation via NOD2/p65 signaling pathway.  INTERNATIONAL IMMUNOPHARMACOLOGY,      [PMID:] [10.1016/j.intimp.2026.116472]
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.